<DOC>
	<DOC>NCT01747941</DOC>
	<brief_summary>The study is designed to test safety tolerability and PK of single oral ascending doses of PF-06305591,</brief_summary>
	<brief_title>Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects</brief_title>
	<detailed_description />
	<criteria>healthy young subjects aged 1855 Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at the time of dosing). Pregnant or nursing females; females of childbearing potential.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>